SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending as the community anticipates the potential launch of a spot XRP ETF, with discussions focusing on the possible impact on price and market dynamics. Bullish sentiment is fueled by expectations of increased institutional investment and potential supply shock, while some caution against overhyping near-term gains. Chatter also includes the government shutdown ending and how that may affect crypto.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is experiencing volatility, with community discussions focusing on a potential market correction despite anticipation surrounding the government reopening; some traders believe the end of the government shutdown will provide much-needed liquidity, while others express concern over potential manipulation and the lack of a significant price surge following the news. Mixed sentiment prevails, with some anticipating a drop towards lower support levels and others suggesting an oversold condition ripe for a rebound.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MLTX is trending as community members discuss recent overnight action and positive data readouts, with many highlighting upcoming catalysts and institutional investment. The conversation centers on the potential for a squeeze, with some suggesting a return to previous highs given upcoming FDA meetings. Community members see it as undervalued.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

CRCL is trending amid discussions around upcoming earnings and the potential impact of the lock-up period expiration, with some traders anticipating a significant drop while others remain bullish. Community members are debating the company's valuation, growth prospects, and competitive positioning in the stablecoin market, with some highlighting insider selling and potential dilution concerns. Despite recent price declines, some investors express optimism about CRCL's long-term potential as a key player in the evolving digital finance landscape.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney's stock is trending as investors anticipate upcoming earnings results and assess the impact of a recent distribution dispute with YouTube TV, which has caused some channel blackouts. Community discussions revolve around the potential for a positive earnings surprise and the company's streaming strategy, with some expressing concerns about content and pricing. Bullish sentiment appears to be building as analysts weigh in on the stock's potential, with a focus on the company's experiences segment and intellectual property monetization.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending as investors await the EMA's decision on Blarcamesine, with discussions focusing on potential approval pathways and the drug's benefits in Alzheimer's treatment. Community chatter revolves around short squeeze potential, the significance of the oral explanation, and speculation on the decision's timing. Despite recent price volatility, longs remain optimistic about the drug's prospects and its potential impact on the Alzheimer's landscape.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending amid renewed buyout speculation after Pfizer's Metsera deal, with investors eyeing VKTX as a potential target given its promising obesity and MASH pipeline. Community discussions revolve around the stock's valuation, potential acquisition price, and the possibility of a partnership with a major healthcare player. Bullish sentiment is fueled by analysts' positive outlook and the belief that VKTX is undervalued compared to its peers in the competitive weight loss market.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is trending amid concerns about debt related to AI buildouts, despite secure contracts with hyperscalers. Community discussions revolve around whether this dip presents a buying opportunity, with some drawing comparisons to Coreweave's situation. Bulls express confidence in long-term fundamentals and potential government contracts.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending due to Shah Capital's renewed push for a company sale, citing frustration with management's performance and a perceived lack of competence, even suggesting intentional underperformance; the community is rallying behind the activist investor, expressing shared concerns about leadership and strategic direction and debating the likelihood and impact of a potential proxy fight or acquisition amid skepticism about current management's ability to unlock value, while highlighting the potential of the Matrix-M adjuvant technology.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

$FNMA is trending as investors react to ongoing speculation around a potential IPO and government actions related to Fannie Mae and Freddie Mac. Community members are closely watching for updates following meetings between key figures and expressing varied opinions on the potential outcomes for common shareholders, with government actions remaining a central focus.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. It offers Epi proColon, a blood-based test for the early detection of colorectal cancer; Epi proLung, a confirmatory test that aids in the diagnosis of lung cancer, Epi BiSKit, a kit for the preparation of purified, bisulfite-converted DNA and, HCCBloodTest, a blood test for cirrhotic patients at high-risk for the development of hepatocellular carcinoma. The company was founded by Oliver Schacht, Christian Piepenbrock, Kurt Berlin, Jörn Walter, and Ivo G. Gut in 1998 and is headquartered in Berlin, Germany.

Epigenomics AG - Registered Shares

Will NVIDIA ($NVDA) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$1.12
Prev Close	$0.95
Open	$1.12
Dividend Yield	0.00%
50-Day Moving Average	$1.12
Beta	0.00
Avg. Volume	0.00
PE Ratio	-0.33

52-Week High	$1.12
52-Week Low	$0.7896
Market Capitalization	$982,200.00
EPS (Annual)	-$4.13
Price to Book	-0.08
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

EPGNF
Epigenomics AG - Registered Shares

Feed

News

Sentiment

Fundamentals

Info

Latest EPGNF News

EPGNFEpigenomics AG - Registered Shares